13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001496201
Total reported value
$766.5M
$766.5M
109 檔
16.1%
At the close of Q3 2024, Sphera Funds Management LTD. disclosed equity holdings valued at approximately $766.5M, spread across 109 reported holdings.
In Q3 2024, Sphera Funds Management LTD. adopted a defensive or profit-taking posture, trimming 41 positions and completely liquidating 25 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 6.12% | +1.19% | -47.51% | |
| 2 | SNY | Sanofi-adr | Stock-Healthcare | 3.76% | -0.56% | -8.90% | |
| 3 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 3.42% | -0.51% | -24.40% | |
| 4 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 3.18% | +0.20% | +25.89% | |
| 5 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 3.14% | -1.06% | EXIT | |
| 6 | NICE | Nice LTD - Spon Adr | Stock-Tech | 3.06% | -0.10% | EXIT | |
| 7 | META | Meta Platforms Inc-class A | Stock-Comm Services | 2.68% | — | -12.33% | |
| 8 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 2.53% | — | +28.57% | |
| 9 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.36% | — | — | |
| 10 | CYTK | Cytokinetics Inc | Stock-Healthcare | 2.32% | +0.43% | -28.55% | |
| 11 | MSFT | Microsoft CORP | Stock-Tech | 2.29% | — | +1.52% | |
| 12 | CLDX | Celldex Therapeutics Inc | Stock-Other | 2.27% | -0.06% | +35.52% | |
| 13 | AAPL | Apple Inc | Stock-Tech | 2.26% | — | -1.06% | |
| 14 | PRAX | Praxis Precision Medicines I | Stock-Other | 2.24% | +0.55% | NEW | |
| 15 | KURA | Kura Oncology Inc | Stock-Other | 1.90% | +0.04% | -0.12% | |
| 16 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.86% | -0.06% | — | |
| 17 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.81% | -0.16% | — | |
| 18 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.73% | -0.13% | -33.52% | |
| 19 | NVMI | Nova Ltd. | Stock-Other | 1.73% | -1.90% | — | |
| 20 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.48% | +0.05% | — | |
| 21 | TSEM | Tower Semiconductor Ltd. | Stock-Tech | 1.48% | -0.38% | +40.00% | |
| 22 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 1.34% | — | — | |
| 23 | HELP | Cybin Inc | Stock-Other | 1.32% | +0.65% | — | |
| 24 | ✓ | Immatics NV | Stock-Other | 1.31% | -0.14% | -1.37% | |
| 25 | PHVS | Pharvaris N.V. | Stock-Other | 1.30% | — | +8.93% | |
| 26 | CATX | Perspective Therapeutics Inc | Stock-Other | 1.25% | — | -25.11% | |
| 27 | CHKP | Check Point Software Technologies Ltd. | Stock-Tech | 1.24% | — | — | |
| 28 | ABBV | Abbvie Inc | Stock-Healthcare | 1.20% | -0.05% | — | |
| 29 | ✓ | Merus N V | Stock-Other | 1.18% | — | — | |
| 30 | ENPH | Enphase Energy Inc | Stock-Tech | 1.16% | -0.86% | EXIT | |
| 31 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.08% | +0.05% | — | |
| 32 | BHVN | Biohaven Ltd. | Stock-Other | 1.06% | -0.48% | — | |
| 33 | S | Sentinelone Inc -class A | Stock-Tech | 1.06% | — | -2.55% | |
| 34 | MRVL | Marvell Technology Inc | Stock-Tech | 1.01% | — | +338.06% | |
| 35 | ✓ | Inozyme Pharma Inc | Stock-Other | 0.99% | — | -18.57% | |
| 36 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 0.99% | -1.37% | EXIT | |
| 37 | SKYE | Skye Bioscience Inc | Stock-Other | 0.98% | -0.01% | +20.43% | |
| 38 | NTLA | Intellia Therapeutics Inc | Stock-Other | 0.95% | — | +108.78% | |
| 39 | RZLT | Rezolute Inc | Stock-Other | 0.93% | — | -29.92% | |
| 40 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 0.92% | +0.12% | — | |
| 41 | WIX | Wix.com Ltd. | Stock-Tech | 0.91% | — | +36.05% | |
| 42 | VIGL | Vigil Neuroscience Inc | Stock-Other | 0.89% | — | -2.63% | |
| 43 | ORA 2.5 07-15-27 SEPTBond | Ormat Technologies Inc | Bond | 0.84% | — | — | |
| 44 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.77% | — | — | |
| 45 | BIIB | Biogen Inc | Stock-Healthcare | 0.76% | +2.85% | -48.42% | |
| 46 | JSPR | Jasper Therapeutics Inc | Stock-Other | 0.75% | — | -44.88% | |
| 47 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 0.70% | — | +25.47% | |
| 48 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 0.68% | — | +12.01% | |
| 49 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 0.65% | -0.37% | — | |
| 50 | ETNBGBP | 89bio Inc | Stock-Other | 0.63% | — | +1.90% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NVMI | Nova Ltd. | +1.7% | NEW | New buy |
| 2 | VKTX | Viking Therapeutics Inc | +1.3% | NEW | New buy |
| 3 | HELP | Cybin Inc | +1.3% | NEW | New buy |
| 4 | CHKP | Check Point Software Technologies Ltd. | +1.2% | NEW | New buy |
| 5 | BHVN | Biohaven Ltd. | +1.1% | NEW | New buy |
| 6 | APLSUSD | Apellis Pharmaceuticals Inc | +1% | NEW | New buy |
| 7 | SNDX | Syndax Pharmaceuticals Inc | +0.9% | +25.89% | Add |
| 8 | ORA 2.5 07-15-27 SEPTBond | Ormat Technologies Inc | +0.8% | NEW | New buy |
| 9 | MRVL | Marvell Technology Inc | +0.8% | +338.06% | Add |
| 10 | SNY | Sanofi-adr | +0.8% | -8.90% | Trim |
| 11 | CLDX | Celldex Therapeutics Inc | +0.7% | +35.52% | Add |
| 12 | TSEM | Tower Semiconductor Ltd. | +0.7% | +40.00% | Add |
| 13 | NTLA | Intellia Therapeutics Inc | +0.5% | +108.78% | Add |
| 14 | CGEM | Cullinan Therapeutics Inc | +0.5% | NEW | New buy |
| 15 | AAPL | Apple Inc | +0.5% | -1.06% | Trim |
| 16 | CRWD | Crowdstrike Holdings Inc - A | +0.5% | NEW | New buy |
| 17 | ✓ | Zura Bio LTD | +0.5% | NEW | New buy |
| 18 | AMZN | Amazon.com Inc | +0.5% | +4.12% | Add |
| 19 | CAMT | Camtek Ltd. | +0.4% | +1770.46% | Add |
| 20 | JNJ | Johnson & Johnson | +0.4% | — | Unchanged |
| 21 | ENPH | Enphase Energy Inc | +0.4% | +13.09% | Add |
| 22 | NICE | Nice LTD - Spon Adr | +0.4% | -2.73% | Trim |
| 23 | SRPT | Sarepta Therapeutics Inc | +0.4% | +28.57% | Add |
| 24 | TVTX | Travere Therapeutics Inc | +0.4% | NEW | New buy |
| 25 | META | Meta Platforms Inc-class A | +0.4% | -12.33% | Trim |
| 26 | WIX | Wix.com Ltd. | +0.4% | +36.05% | Add |
| 27 | AZNN | Astrazeneca Plc-spons Adr | +0.3% | — | Unchanged |
| 28 | DYN | Dyne Therapeutics Inc | +0.3% | NEW | New buy |
| 29 | VRDN | Viridian Therapeutics Inc | +0.3% | NEW | New buy |
| 30 | ALNY | Alnylam Pharmaceuticals Inc | +0.3% | NEW | New buy |
| 31 | PTCT | Ptc Therapeutics Inc | +0.3% | +25.47% | Add |
| 32 | ✓ | +0.3% | NEW | New buy | |
| 33 | ABBV | Abbvie Inc | +0.3% | — | Unchanged |
| 34 | WDAY | Workday Inc-class A | +0.3% | NEW | New buy |
| 35 | MSFT | Microsoft CORP | +0.3% | +1.52% | Add |
| 36 | PHVS | Pharvaris N.V. | +0.3% | +8.93% | Add |
| 37 | S | Sentinelone Inc -class A | +0.2% | -2.55% | Trim |
| 38 | LLY | Eli Lilly & Co | +0.2% | — | Unchanged |
| 39 | PRAX | Praxis Precision Medicines I | +0.2% | -31.84% | Trim |
| 40 | SRRK | Scholar Rock Holding CORP | +0.2% | NEW | New buy |
| 41 | ORIC | Oric Pharmaceuticals Inc | +0.2% | NEW | New buy |
| 42 | CRGX | Cargo Therapeutics Inc | +0.2% | +22.51% | Add |
| 43 | NVS | Novartis Ag-sponsored Adr | +0.2% | — | Unchanged |
| 44 | KURA | Kura Oncology Inc | +0.2% | -0.12% | Trim |
| 45 | CATX | Perspective Therapeutics Inc | +0.2% | -25.11% | Trim |
| 46 | CAPR | Capricor Therapeutics Inc | +0.2% | NEW | New buy |
| 47 | PLRX | Pliant Therapeutics Inc | +0.2% | +15.01% | Add |
| 48 | ✓ | Immatics NV | +0.2% | -1.37% | Trim |
| 49 | NVDA | Nvidia CORP | +0.1% | +21.77% | Add |
| 50 | LRMR | Larimar Therapeutics Inc | +0.1% | +32.65% | Add |
According to official SEC Form 13F filings, Sphera Funds Management LTD. reported a total U.S. public equity portfolio value of $766.5M across 109 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TEVA, SNY, BBIO) accounted for 16.1% of total reported equity market value during Q3 2024.
Top New Position Initiated
NVMI
市值: $10.8M
Top Position Liquidated / Trimmed
SMH
前期市值: $39.1M
During Q3 2024, Sphera Funds Management LTD.'s top holdings by market value included TEVA (6.1%)、SNY (3.8%)、BBIO (3.4%). The largest single position, TEVA, represented 6.1% of total portfolio value.
In Q3 2024, Sphera Funds Management LTD. made 113 total portfolio adjustments, initiating 21 new buys, adding to 26 positions, trimming 41 holdings, and fully liquidating 25 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.